Immune Globulin (Human) (Baygam, Gamastan S/D)
Immune Globulin (Human) is an FDA-licensed reference biologic from Grifols Therapeutics LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1944
Reference approved
Reference product
Baygam, Gamastan S/D Immune Globulin (Human)
Grifols Therapeutics LLC
- Approved
- Jan 11, 1944
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Immune Globulin (Human), in chronological order.
Reference approval
Approval date of the reference Immune Globulin (Human) product.
83 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for Immune Globulin (Human) (Baygam, Gamastan S/D)?
No 351(k) biosimilars or interchangeable biosimilars referencing Immune Globulin (Human) are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.